Skip to content

Clinical trials

Phase 3 Sleep Apnea, Obstructive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Phase: Phase 3 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20091
20111
20123
20152
20221
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Enrolling by invitation1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon3
Amgen2
Apnimed2
Eli Lilly and Company2
Jazz Pharmaceuticals2
Children's & Women's Health Centre of British Columbia1
Hamilton Health Sciences Corporation1
McMaster University1
Novo Nordisk A/S1
OSR Medical Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive18
Obesity5
Narcolepsy3
Overweight3
Disorders of Excessive Somnolence2
Agnosia1
Apnea1
Lymphoma, Follicular1
Nutrition Disorders1
Osteoarthritis, Knee1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.